acyclovir
Generic: acyclovir
Labeler: ani pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
ani pharmaceuticals, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
acyclovir 200 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
70954-188
Product ID
70954-188_87d55aa5-78a8-458e-9a82-f4f36d9d1c9b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212252
Listing Expiration
2027-12-31
Marketing Start
2020-07-13
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70954188
Hyphenated Format
70954-188
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA212252 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/5mL
Packaging
- 473 mL in 1 BOTTLE (70954-188-10)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "87d55aa5-78a8-458e-9a82-f4f36d9d1c9b", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0370954188100"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["8208711c-18ba-4615-b932-3c0bb7e6efae"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (70954-188-10)", "package_ndc": "70954-188-10", "marketing_start_date": "20200713"}], "brand_name": "acyclovir", "product_id": "70954-188_87d55aa5-78a8-458e-9a82-f4f36d9d1c9b", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70954-188", "generic_name": "acyclovir", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA212252", "marketing_category": "ANDA", "marketing_start_date": "20200713", "listing_expiration_date": "20271231"}